Leszek Czupryniak

61 Zwirki I Wigury Street
Warsaw, MZ 02091, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Admission Glucose and Presenting Symptoms in Relation to Disease Stage in Newly Diagnosed Pancreatic Ductal Adenocarcinoma.

Admission Glucose and Presenting Symptoms in Relation to Disease Stage in Newly Diagnosed Pancreatic Ductal Adenocarcinoma.

Journal: Journal of clinical medicine

Published: July 02, 2026

Interpreting Low Glucose Values Below 3.9 mmol/L (70 mg/dL) in People Without Diabetes in the Era of Continuous Glucose Monitoring.

Interpreting Low Glucose Values Below 3.9 mmol/L (70 mg/dL) in People Without Diabetes in the Era of Continuous Glucose Monitoring.

Journal: Diabetes, obesity & metabolism

Published: June 12, 2026

The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence.

The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: May 26, 2026

Five-Year Evolution of the Microbiological Landscape of Diabetic Foot Infections (2021-2025): Rising Polymicrobial Gram-Negative Predominance and Emergence of Resistant Enterobacterales at a Single Large-Volume Outpatient Centre.

Five-Year Evolution of the Microbiological Landscape of Diabetic Foot Infections (2021-2025): Rising Polymicrobial Gram-Negative Predominance and Emergence of Resistant Enterobacterales at a Single Large-Volume Outpatient Centre.

Journal: Antibiotics (Basel, Switzerland)

Published: May 24, 2026

A Practical Perspective on Confronting the Obesity Epidemic: Public-Health Strategies.

A Practical Perspective on Confronting the Obesity Epidemic: Public-Health Strategies.

Journal: Nutrients

Published: May 21, 2026

Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy.

Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy.

Journal: Diabetes, obesity & metabolism

Published: May 09, 2026

Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes.

Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes.

Journal: International journal of molecular sciences

Published: December 31, 2025

Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review.

Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review.

Journal: Frontiers in clinical diabetes and healthcare

Published: December 20, 2025

New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review.

New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review.

Journal: Anaesthesiology intensive therapy

Published: September 25, 2025

Type 2 Diabetes and Gastrointestinal Cancers: Risk Associations and Awareness of Screening Challenges.

Type 2 Diabetes and Gastrointestinal Cancers: Risk Associations and Awareness of Screening Challenges.

Journal: Cancers

Published: August 08, 2025

Cross-Sectional Study of Serum Galectin-3 Levels in Patients with Type 2 Diabetes and Colorectal Polyps.

Cross-Sectional Study of Serum Galectin-3 Levels in Patients with Type 2 Diabetes and Colorectal Polyps.

Journal: International journal of molecular sciences

Published: July 07, 2025

Differences in the Perception of Snacks and Beverages Portion Sizes Depending on Body Mass Index.

Differences in the Perception of Snacks and Beverages Portion Sizes Depending on Body Mass Index.

Journal: Nutrients

Published: May 25, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026